Calisa Acquisition Units (ALISU) vs Drugs Made In America Acquisition - Units (DMAAU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALISU | DMAAU |
|---|---|---|
| Share price | $27.89 | $10.79 |
| 1-day change | -30.27% | 0.00% |
| YTD return | +282.78% | +4.77% |
| 1-year return | — | +4.27% |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $52.99 | $12.50 |
| 52-week low | $9.98 | $10.30 |
| Distance from 52-week high | -47.37% | -13.68% |
| Average volume | 1.20K | 25 |
| Shares outstanding | — | 29.17M |
| Sector | Financial Services | Financial Services |
| Industry | Shell Companies | Shell Companies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Calisa Acquisition Units
ALISU stock →Calisa Acquisition Corp does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities.
Financial Services · Shell Companies
About Drugs Made In America Acquisition - Units
DMAAU stock →Drugs Made In America Acquisition Corp. does not have significant operations.
Financial Services · Shell Companies
ALISU vs DMAAU FAQ
Are Calisa Acquisition Units and Drugs Made In America Acquisition - Units in the same industry?
Yes. Both are classified in the Shell Companies industry within the Financial Services sector.